Fuertes, Melody A.
HRN: 22-59-91 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/14/2025
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
01/14/2025
01/21/2025
TOPICAL
1%
OD
Dm Foot
Waiting Final Action
Indication: Empiric Type of Infection: Bone & JointSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes